Funder
U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Bateman BT, Hernandez-Diaz S, Rathmell JP, Seeger JD, Doherty M, Fischer MA, et al. Patterns of opioid utilization in pregnancy in a large cohort of commercial insurance beneficiaries in the United States. Anesthesiol. 2014;120:1216–24.
2. Desai RJ, Hernandez-Diaz S, Bateman BT, Huybrechts KF. Increase in prescription opioid use during pregnancy among Medicaid-enrolled women. Obstet Gynecol. 2014;123:997–1002.
3. US Centers for Disease Control and Prevention. Vital signs: overdoses of prescription opioid pain relievers—United States, 1999–2008. Morb Mortal Wkly Rep. 2011;60:1487–92.
4. Maclean JC, Witman A, Durrance CP, Atkins DN, Meinhofer A. Prenatal substance use policies and infant maltreatment reports: study examines prenatal substance use policies and infant maltreatment reports. Health Aff. 2022;41:703–12.
5. Pac J, Durrance C, Berger L, Ehrenthal DB. The effects of opioid use during pregnancy on infant health and well-being. Ann Am Acad Pol Soc Sci. 2022;703:106–38.